MedTrace Logo

Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/CBCT)

NCT03231046 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-07-27

No results posted yet for this study

Summary

The objective of this research is to evaluate functional validation of the CBCT-US fusion for the Clear Guide SCENERGY system, as well as to evaluate benefits derived from system performance.

Conditions

  • Hepatic Biopsy or Ablation

Interventions

DEVICE

CBCT-US Fusion Arm

Use of Clear Guide SCENERGY for CBCT-US fusion guidance

PROCEDURE

Hepatic Biopsy or Ablation

Standard of Care

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-03-31
Completion
2019-03-31
FDA Device
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03231046 on ClinicalTrials.gov